Niantic Spatial has now made its WebAR creation platform ‘8th Wall’ free and open source, which also comes alongside a shutdown of hosted services. Previously a paid service, 8th Wall allows users to ...

Stuck on Protect/Destroy 1 in Marathon? Here’s where to find the Biosample Analyzer and the closest DCON bunker.

MADISON, Wis.--(BUSINESS WIRE)--Nearly seven in 10 Americans who have taken a GLP-1 medication say the drug’s cost influenced their decision to start or continue treatment, according to a new ...

Nearly seven in 10 Americans who have taken a GLP-1 medication say the drug’s cost influenced their decision to start or continue treatment, according to a new nationwide Navitus Health Solutions ...

Share on Pinterest Reports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/Shutterstock Reports of GLP-1 users developing scurvy have increased in recent months ...

Reports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/Shutterstock Maybe you’ve been using a GLP-1 medication for a while now, and you’ve started to notice ...

Cost materially shaped access, with 68% reporting it influenced starting or continuing GLP-1 therapy across commonly used agents for diabetes and weight management. Out-of-pocket burden was ...

“Micronutrient deficiencies during GLP-1 therapy are a common consequence rather than a rare adverse effect. Additionally, findings illustrate that GLP-1 RA [receptor agonist]-associated nutritional ...

McDonald’s Corporation (NYSE: MCD) is adapting its menu as a growing number of Americans on GLP-1 weight-loss drugs, such as Ozempic and Wegovy, alter portion sizes, snacking habits, and beverage ...

McDonald’s signaled this week it’s looking to better cater to customers on weight-loss drugs — and the name of the game is protein. During a Wednesday earnings call, McDonald’s CEO Chris Kempczinski ...

THG has struck a licensing deal for its Myprotein brand with manufacturing group Greencore to target consumers using GLP-1 weight-loss injections. Under the deal, Greencore will produce a range of ...

A recent white paper determines that the link between GLP-1 agonist inhibitors and thyroid cancer is unconvincing. A new white paper issued by the Clayman Thyroid Center in Tampa, Florida, concludes ...